(2015) Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option? Jama Neurology. pp. 1407-1408. ISSN 2168-6149
Full text not available from this repository.
Official URL: http://apps.webofknowledge.com/InboundService.do?F...
Abstract
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?
Item Type: | Article |
---|---|
Keywords: | rituximab |
Page Range: | pp. 1407-1408 |
Journal or Publication Title: | Jama Neurology |
Journal Index: | ISI |
Volume: | 72 |
Number: | 12 |
Identification Number: | https://doi.org/10.1001/jamaneurol.2015.2869 |
ISSN: | 2168-6149 |
Depositing User: | مهندس مهدی شریفی |
URI: | http://eprints.mui.ac.ir/id/eprint/4457 |
Actions (login required)
View Item |